Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Ceska Gynekol ; 88(5): 347-352, 2023.
Article in English | MEDLINE | ID: mdl-37932051

ABSTRACT

OBJECTIVE: To describe the implementation process and evaluate the success of compliance with the recommended ERAS protocol in the Czech healthcare system. METHODS: The study included 163 patients from March to September 2022, a total of 7 months. Patients were divided into three groups according to the type of surgery. Clinical protocol: Oncogynecology, hysterectomy and laparoscopy. The implementation was realized in three phases (preparation, implementation of the protocol itself and evaluation). RESULTS AND CONCLUSIONS: The cumulative adherence rate was 90% or more in all three groups. Based on the pilot results at our department, we evaluated the ERAS concept as a well-implemented tool for gynaecological departments in the Czech healthcare system.


Subject(s)
Gynecology , Laparoscopy , Female , Humans , Clinical Protocols , Pilot Projects , Postoperative Complications , Guideline Adherence
2.
Vnitr Lek ; 66(5): 69-71, 2020.
Article in English | MEDLINE | ID: mdl-32942873

ABSTRACT

Prevalence of type 2 diabetes in the Czech Republic can be estimated from data reported by health care providers either to the statistical office or to health insurers. The latter include both diagnosis and prescribed drugs. Patient classification to a certain chronic condition based on consumption of drugs (Pharmacy-based Cost Groups classification) has been used in the Czech Republic for the purpose of redistribution of collected funds among health insurers since the beginning of 2018. This article compares prevalence of diabetes estimated from statistical data and from data reported to health insurers, and discusses current and future advantages and disadvantages of all methodologies. Diagnoses reporting in outpatient care are considered to be inaccurate, on the other hand peroral antidiabetics do not seem to be prescribed to all indicated patients. The appropriate approach to prevalence estimation from data reported to health insurers is becoming even more important after the creation of National Diabetes Register based on insurance data and the related abatement of direct reporting to the statistical office.


Subject(s)
Diabetes Mellitus, Type 2 , Ambulatory Care , Czech Republic/epidemiology , Diabetes Mellitus, Type 2/epidemiology , Humans , Hypoglycemic Agents/therapeutic use , Prevalence
SELECTION OF CITATIONS
SEARCH DETAIL
...